Chingsong Health: April 2026 Monthly Revenue NT$106 Million (YoY +12.7%)
Taiwanese biotechnology and medical company Chingsong Health announced its April 2026 monthly revenue reached NT$106 million, a 12.7% increase year-on-year, indicating stable growth in the biotechnology and medical market.
📋 Article Processing Timeline
- 📰 Published: April 1, 2026 at 09:00
- 🔍 Collected: May 12, 2026 at 08:00 (983h 0m after Published)
- 🤖 AI Analyzed: May 12, 2026 at 09:26 (1h 26m after Collected)
Company Code: 6931
Company Name: Chingsong Health
Industry: Biotechnology and Medical Industry
Data Month: 2026-04
Monthly Revenue: 105,742 thousand TWD (NT$106 million)
Year-on-year Change: +12.7%
Company Name: Chingsong Health
Industry: Biotechnology and Medical Industry
Data Month: 2026-04
Monthly Revenue: 105,742 thousand TWD (NT$106 million)
Year-on-year Change: +12.7%